A weight loss drug similar to Ozempic appeared to slow cognitive decline in patients with mild Alzheimer’s disease, new research presented Tuesday at the Alzheimer’s Association International Conference in Philadelphia finds.

The findings, which have not yet been published in a peer-reviewed…